Evidence map›Paper›PMID 27380043›Full record

ArticleCellular and molecular neurobiology2017

Tetramethylpyrazine Protects Against Oxygen-Glucose Deprivation-Induced Brain Microvascular Endothelial Cells Injury via Rho/Rho-kinase Signaling Pathway.

Guang Yang, Chen Qian, Ning Wang, Chenyu Lin, Yan Wang, Guangyun Wang, Xinxin Piao

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. [Astragalus polysaccharide protects against blood-brain barrier damage in MCAO rats by inhibiting P2X7R channel].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Guang YangKey Laboratory of Xin'an Medicine, Ministry of Education, Hefei, 230012, China.
Chen QianKey Laboratory of Xin'an Medicine, Ministry of Education, Hefei, 230012, China.
Ning WangKey Laboratory of Xin'an Medicine, Ministry of Education, Hefei, 230012, China. wnhefei@163.com.
Chenyu LinKey Laboratory of Xin'an Medicine, Ministry of Education, Hefei, 230012, China.
Yan WangKey Laboratory of Xin'an Medicine, Ministry of Education, Hefei, 230012, China.
Guangyun WangKey Laboratory of Xin'an Medicine, Ministry of Education, Hefei, 230012, China.
Xinxin PiaoKey Laboratory of Xin'an Medicine, Ministry of Education, Hefei, 230012, China.
Ministry of Education of the People's Republic of China · CNHefei Institutes of Physical Science · CNAnhui University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetramethylpyrazine (TMP, also known as Ligustrazine), which is isolated from Chinese Herb Medicine Ligustium wollichii Franchat (Chuan Xiong), has been widely used in China for the treatment of ischemic stroke by Chinese herbalists. Brain microvascular endothelial cells (BMECs) are the integral parts of the blood-brain barrier (BBB), protecting BMECs against oxygen-glucose deprivation (OGD) which is important for the treatment of ischemic stroke. Here, we investigated the protective mechanisms of TMP, focusing on OGD-injured BMECs and the Rho/Rho-kinase (Rho-associated kinases, ROCK) signaling pathway. The model of OGD-injured BMECs was established in this study. BMECs were identified by von Willebrand factor III staining and exposed to fasudil, or TMP at different concentrations (14.3, 28.6, 57.3 µM) for 2 h before 24 h of OGD injury. The effect of each treatment was examined by cell viability assays, measurement of intracellular reactive oxygen species (ROS), and transendothelial electric resistance and western blot analysis (caspase-3, endothelial nitric oxide synthase (eNOS), RhoA, Rac1). Our results show that TMP significantly attenuated apoptosis and the permeability of BMECs induced by OGD. In addition, TMP could notably down-regulate the characteristic proteins in Rho/ROCK signaling pathway such as RhoA and Rac1, which triggered abnormal changes of eNOS and ROS, respectively. Altogether, our results show that TMP has a strong protective effect against OGD-induced BMECs injury and suggest that the mechanism might be related to the inhibition of the Rho/ROCK signaling pathway.

Indexed as

AnimalsBlood-Brain BarrierBrainCells, CulturedDrugs, Chinese HerbalEndothelial CellsGlucoseMaleMicrovesselsNitric Oxide Synthase Type IIIOxygenProtective AgentsPyrazinesRats, Sprague-Dawleyrho-Associated KinasesSignal TransductionDrugs, Chinese HerbalGlucoseNitric Oxide Synthase Type IIIOxygenProtective AgentsPyrazinesrho-Associated KinasestetramethylpyrazineBrain microvascular endothelial cells (BMECs)Oxygen-glucose deprivation (OGD)Rho/ROCK signaling pathwayTetramethylpyrazine (TMP)

Identifiers

PMID27380043
PMCPMC11482156
OpenAlexW2469495620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.